Lv4
758 积分 2024-06-28 加入
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
24天前
已完结
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial
1个月前
已完结
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice
2个月前
已完结
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer
2个月前
已完结
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD
2个月前
已完结
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
3个月前
已完结
TROP2-directed antibody-drug conjugates: new first-line treatment for all patients with advanced triple-negative breast cancer?
3个月前
已完结
Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers
4个月前
已完结
BAT mitochondria: whitening meets softening
1年前
已采纳
Tripeptide armour shields encapsulated proteins
1年前
已采纳
Tripeptide armour shields encapsulated proteins
1年前
已采纳
Tripeptide armour shields encapsulated proteins
1年前
已采纳
Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
1年前
已撤回
Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
1年前
已采纳
Gastric precancerous process in a high risk population: cohort follow-up
1年前
已采纳
皖公网安备34019202002308
